Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia
NCT00868127
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
574
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypercholesterolemia
Interventions
DRUG:
Lapaquistat acetate
DRUG:
Lapaquistat acetate and additional lipid-lowering therapy
Sponsor
Takeda